pancreatic cancer
Showing 1 - 25 of 1,502
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen
Recruiting
- Pancreatic Cancer
- +3 more
- Bio-specimen Collection: Blood
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023
Pancreatic Cancer Trial in Dublin (Control, Intervention)
Not yet recruiting
- Pancreatic Cancer
- Control
- Intervention
-
Dublin, Leinster, IrelandSt Vincent's University Hospital
Nov 20, 2023
Pancreatic Cancer, Surgery Trial in København, Køge (Propranolol, Placebo)
Not yet recruiting
- Pancreatic Cancer
- Surgery
- Propranolol
- Placebo
-
København, Denmark
- +1 more
Nov 17, 2023
Colorectal Cancer, Pancreatic Cancer Trial in Hangzhou (Bemalenograstim alfa)
Not yet recruiting
- Colorectal Cancer
- Pancreatic Cancer
- Bemalenograstim alfa
-
Hangzhou, Chinathe Second Affiliated Hospital of Medical College of Zhejiang Un
Nov 14, 2023
Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)
Not yet recruiting
- Gastric Cancer
- +2 more
- KD-496
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Nov 15, 2023
LIver, Biliary tRAct and pancReatic Cancers
Recruiting
- Liver Cancer
- +2 more
- Blood drawing
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023
Candidates for Neoadjuvant Treatment in Resectable Pancreatic
Completed
- Pancreatic Cancer
- Neoadjuvant
- Neoadjuvant treatment
- (no location specified)
Nov 9, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)
Not yet recruiting
- Pancreatic Cancer
- +4 more
- Screening Blood Tests
- +3 more
-
Boston, Massachusetts
- +1 more
Nov 3, 2023
Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,
Not yet recruiting
- Pancreatic Cancer
- TTX-030, nab-paclitaxel and gemcitabine
- +2 more
- (no location specified)
Nov 3, 2023
Cholangitis, Pancreatic Cancer, Choledocholithiasis Trial in Cheras (Ketamine, Midazolam, Pethidin)
Recruiting
- Cholangitis
- +3 more
- Ketamine
- +2 more
-
Cheras, Kuala Lumpur, MalaysiaHospital Canselor Tuanku Muhriz UKM
Oct 26, 2023
Pancreatic Cancer Trial in Tainan (pancreatectomy)
Completed
- Pancreatic Cancer
- pancreatectomy
-
Tainan, TaiwanNational Cheng Kung University Hospital
Oct 22, 2023
Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)
Not yet recruiting
- Gastrointestinal Cancer
- +5 more
- BI 765049
- Ezabenlimab
- (no location specified)
Oct 16, 2023
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Palliative Therapy for Pancreatic Cancer Patient
Recruiting
- Pancreatic Cancer
- Observational study
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 17, 2023
Quality of Life in Elderly Patients After Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- +2 more
- Phone call
-
Lyon, FranceService de Gériatrie aigue, Hôpital Edouard Herriot, Hospices Ci
Oct 6, 2023
Gastric Outlet Obstruction, Pancreatic Cancer Trial in Worldwide
Not yet recruiting
- Gastric Outlet Obstruction
- Pancreatic Cancer
-
Paris, France
- +4 more
Oct 6, 2023
Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
- BNT321 Dose Level 1
- +3 more
- (no location specified)
Sep 29, 2023
Pancreatic Cancer, Periampullary Cancer, Frailty Syndrome Trial in Milan (Multimodal Prehabilitation)
Recruiting
- Pancreatic Cancer
- +4 more
- Multimodal Prehabilitation
-
Milan, Lombardia, ItalySan Raffaele Hospital
Sep 29, 2023
Pancreatic Cancer Trial in Tampa (Quality fo Life Questionnaire (FHSI), Vioscreen Food Frequency Questionnaire (FFQ),
Recruiting
- Pancreatic Cancer
- Quality fo Life Questionnaire (FHSI)
- +6 more
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2023
Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))
Recruiting
- Pancreatic Cancer
- TCR-T Cells Injection(GB3010 Cells Injection)
-
ShangHai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023